SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001607062-16-000576
Filing Date
2016-01-07
Accepted
2016-01-07 14:00:24
Documents
53
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K rgbp010516form10k.htm 10-K 1365424
2 EXHIBIT 10.54 ex10_54.htm EX-10.54 35492
3 EXHIBIT 10.55 ex10_55.htm EX-10.55 30990
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 8288
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 10890
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 5065
7 EXHIBIT 32.2 ex32_2.htm EX-32.2 5613
  Complete submission text file 0001607062-16-000576.txt   3337392

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE rgbp-20150930.xml EX-101.INS 298456
9 XBRL SCHEMA FILE rgbp-20150930.xsd EX-101.SCH 38311
10 XBRL CALCULATION FILE rgbp-20150930_cal.xml EX-101.CAL 27703
11 XBRL DEFINITION FILE rgbp-20150930_def.xml EX-101.DEF 136165
12 XBRL LABEL FILE rgbp-20150930_lab.xml EX-101.LAB 193176
13 XBRL PRESENTATION FILE rgbp-20150930_pre.xml EX-101.PRE 173593
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 333-191725 | Film No.: 161329886
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences